内皮RUNX3调控肝窦内皮细胞功能障碍及血管分泌LRG1信号以预防肝纤维化
本研究探讨内皮RUNX3在肝窦内皮细胞门控功能及肝纤维化中的作用。内皮Runx3缺失小鼠出现自发性肝纤维化并更易发生肝损伤,机制涉及IL-6/JAK/STAT3通路激活及LRG1分泌,后者通过TGFBR1-SMAD2/3旁分泌激活肝星状细胞。肝纤维化小鼠及脂肪肝、肝硬化患者循环LRG1水平升高。
要点
- 内皮Runx3缺失小鼠发生自发性肝纤维化,并更易发生肝损伤。
- RUNX3缺失的肝窦内皮细胞高表达并分泌LRG1,旁分泌激活肝星状细胞。
- 肝纤维化小鼠及脂肪肝、肝硬化患者循环LRG1水平升高。
核心结论
- 内皮RUNX3缺失诱导肝窦内皮细胞功能障碍、LRG1分泌及肝纤维化进展。
- 内皮RUNX3是肝窦内皮细胞重要的门控因子,促纤维化血管分泌LRG1可能是抗肝纤维化的新靶点。
研究设计与样本
- 研究采用内皮Runx3缺陷小鼠模型,并在人永生化肝窦内皮细胞和小鼠原代肝窦内皮细胞中进行机制研究。
主要发现
- 内皮Runx3缺陷小鼠出现逐渐且自发的肝纤维化,继发于肝窦内皮细胞功能障碍,并更易发生肝损伤。
- 在缺乏RUNX3时,IL-6/JAK/STAT3通路激活与肝窦内皮细胞功能障碍相关。
- 单细胞RNA测序和定量RT-PCR显示LRG1在RUNX3缺陷及功能障碍的肝窦内皮细胞中高表达。
- 体外和共培养实验中,RUNX3缺失的肝窦内皮细胞分泌LRG1,通过TGFBR1-SMAD2/3信号以旁分泌方式激活肝星状细胞。
- 循环LRG1水平在肝纤维化小鼠模型及脂肪肝和肝硬化患者中升高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Liver fibrosis represents a global health burden, given the paucity of approved antifibrotic therapies. Liver sinusoidal endothelial cells (LSECs) play a major gatekeeping role in hepatic homeostasis and liver disease pathophysiology. In early tumorigenesis, runt-related transcription factor 3 (RUNX3) functions as a sentinel; however, its function in liver fibrosis in LSECs remains unclear. This study aimed to investigate the role of RUNX3 as an important regulator of the gatekeeping functions of LSECs and explore novel angiocrine regulators of liver fibrosis. APPROACH AND RESULTS: Mice with endothelial Runx3 deficiency develop gradual and spontaneous liver fibrosis secondary to LSEC dysfunction, thereby more prone to liver injury. Mechanistic studies in human immortalized LSECs and mouse primary LSECs revealed that IL-6/JAK/STAT3 pathway activation was associated with LSEC dysfunction in the absence of RUNX3. Single-cell RNA sequencing and quantitative RT-PCR revealed that leucine-rich alpha-2-glycoprotein 1 ( LRG1 ) was highly expressed in RUNX3-deficient and dysfunctional LSECs. In in vitro and coculture experiments, RUNX3-depleted LSECs secreted LRG1, which activated HSCs throughTGFBR1-SMAD2/3 signaling in a paracrine manner. Furthermore, circulating LRG1 levels were elevated in mouse models of liver fibrosis and in patients with fatty liver and cirrhosis. CONCLUSIONS: RUNX3 deficiency in the endothelium induces LSEC dysfunction, LRG1 secretion, and liver fibrosis progression. Therefore, endothelial RUNX3 is a crucial gatekeeping factor in LSECs, and profibrotic angiocrine LRG1 may be a novel target for combating liver fibrosis.
引用
- Ojha U, Kim S, Rhee CY, et al. Endothelial RUNX3 controls LSEC dysfunction and angiocrine LRG1 signaling to prevent liver fibrosis. Hepatology. 2024. PMID: 39042837. doi:10.1097/HEP.0000000000001018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。